Your cart

There are no items in your shopping cart

Deucravacitinib - BMS986165

Based on 101 reference(s) in Google Scholar 8 10 101

Axon 4091

CAS [1609392-27-9]

MF C20H19D3N8O3
MW 425.46

  • Purity: 98%
  • Soluble in DMSO

Deucravacitinib

Description

Deucravacitinib is a potent, highly selective, allosteric and orally bioavailable inhibitor of tyrosine kinase 2 (TYK2) with an IC50 value of 0.20 nM. Deucravacitinib shows excellent pharmacokinetic properties with minimal profiling liabilities and is efficacious in several murine models of autoimmune disease.

KEYWORDS: Deucravacitinib | Supplier | TYK2 inhibitor | BMS986165 | BMS 986165 | BMS-986165 | CAS [1609392-27-9] | [1609392-28-0] | JAK-STAT Pathway | JAK | Inhibitor | Enzymes | Autoimmune disease | JH2 ligand | TYK2 pseudokinase (JH2) domain

Potent, highly selective, allosteric and orally bioavailable TYK2 inhibitor

Chemical name

6-(Cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide

Parent CAS No.

[1609392-27-9]

Order
Size Unit Price Stock
5 mg €150.00 In Stock
25 mg €490.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €240.00 In Stock
2 x 25 mg €780.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
3950 Peficitinib Potent and orally bioavailable JAK inhibitor €120.00
4006 GLPG-0634 The first orally-available, selective inhibitor of JAK1 Inquire

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...